GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Endoscopy/SOCCER Trial: Forceps Boost Cannulation Success in Difficult ERCP- AJG Feb.26

SOCCER Trial: Forceps Boost Cannulation Success in Difficult ERCP- AJG Feb.26

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated February 1, 2026

Quick Answer

Introduction Difficult biliary cannulation remains one of the most common and consequential problems in ERCP. Failed cannulation drives repeat procedures, percutaneous or surgical rescue, higher costs, longer hospital stay—and it also increases post-ERCP pancreatitis (PEP) risk because repeated attempts and unintended pancreatic duct (PD) wire passes are key triggers.


Introduction

Difficult biliary cannulation remains one of the most common and consequential problems in ERCP. Failed cannulation drives repeat procedures, percutaneous or surgical rescue, higher costs, longer hospital stay—and it also increases post-ERCP pancreatitis (PEP) risk because repeated attempts and unintended pancreatic duct (PD) wire passes are key triggers.

Forceps-assisted cannulation has been used as a “trick” in challenging papillae (periampullary diverticulum, redundant folds, awkward papilla orientation), but until now it lacked randomized controlled trial evidence.

The SOCCER trial tests a simple question:

Does forceps-assisted cannulation improve success when cannulation is difficult?

Problem statement

When cannulation becomes difficult, endoscopists typically escalate to:

double-wire techniques,

precut/needle-knife access,

PD stenting strategies, etc.

These can be effective but may increase complexity and sometimes risk. A low-cost mechanical approach—using forceps to expose and stabilize the papilla—could reduce failure and potentially reduce repeated traumatic attempts. But its true efficacy needed an RCT.

What the trial did:

Randomized adults with difficult cannulation scenarios during ERCP to:

forceps-assisted cannulation, or

standard cannulation without forceps

“Difficult” included:

papilla in/on a diverticulum,

redundant tissue overlying the papilla,

challenging papilla morphology (type 2–4),

or difficult cannulation defined by attempts/time/unintended PD wire passages.

Primary outcome: successful cannulation

Secondary: difficult cannulation metrics after randomisation and PEP

Key results clinicians should remember

1) Cannulation success improved substantially with forceps

Forceps assistance achieved near-universal cannulation success in this difficult subset, while standard cannulation had a meaningful failure rate.

2) Crossover to forceps rescued failures

All patients who failed initial standard cannulation and then crossed over to forceps were successfully cannulated—suggesting forceps is a reliable rescue option.

3) Forceps reduced the “trauma load” of cannulation

Even when overall difficult-cannulation rates didn’t reach statistical significance, the forceps approach resulted in fewer cannulation attempts, which is clinically important because attempts correlate with PEP risk.

4) PEP rates were low and similar in both groups

This suggests the technique improves access without adding measurable pancreatitis risk in this trial setting.

Clinical interpretation: where this fits tomorrow

This trial supports forceps-assisted cannulation as a practical, low-cost, low-complexity tool in ERCP—especially when the papilla is hard to expose or stabilize.

Best-use scenarios

periampullary diverticulum (papilla in/on rim)

redundant folds/tissue obscuring papilla

small/protruding/creased papilla configurations (type 2–4)

early difficult cannulation where you want to avoid escalating to higher-risk access

What it does not replace

precut access when anatomy/duct orientation truly prevents standard entry

prophylaxis strategies (rectal NSAID, PD stent when indicated)

thoughtful escalation algorithms

Bottom-line takeaway for GastroAGI

In difficult ERCP cannulation, forceps assistance significantly improves cannulation success and reduces repeated attempts, without a signal for increased PEP. The SOCCER RCT moves forceps-assisted cannulation from “expert trick” to evidence-supported technique.

One-line GastroAGI takeaway

When cannulation gets difficult, forceps assistance can turn failures into successes.

Related Q&A

EndoBarrier Improves Diabetes and Weight Loss: Ann Surg | July 2026

Introduction: Endoscopic metabolic therapies have emerged as less invasive alternatives to bariatric surgery for patients with obesity and poorly controlled type 2 diabetes mellitus (T2DM). The EndoBarrier duodenal-jejunal bypass liner (DJBL) is an endoscopically placed...

Immediate Endoscopic Necrosectomy in Necrotizing Pancreatitis: Gastroenterology | July 2026

Introduction: Endoscopic ultrasound (EUS)-guided transmural drainage is the standard minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves...

Endoscopy After Bevacizumab Appears Safe: GIE | July 2026

Introduction: Bevacizumab is widely used in metastatic colorectal cancer (mCRC) because of its survival benefits but is associated with impaired wound healing, gastrointestinal perforation, and bleeding. These concerns often lead clinicians to delay endoscopic procedures...

Colorectal ESD Perforation: Endoscopy | July 2026

Introduction: Endoscopic submucosal dissection (ESD) enables en bloc resection of large colorectal neoplasms with excellent oncological outcomes. However, concerns about perforation have limited its widespread adoption. This large prospective multicenter study evaluated the incidence, risk...

Duodenal Mucosal Resurfacing REMAIN-1 Study: DDW | 2026

Introduction: Obesity has become one of the greatest global health challenges. New incretin-based therapies—including semaglutide, tirzepatide, resmetirom, and SGLT2 inhibitors such as empagliflozin—have transformed the treatment of obesity, diabetes, and MASLD. However, many patients discontinue...

EUS-FNAB for Solid Pancreatic Lesions: GIE | July 2026

Introduction: Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is the standard technique for diagnosing solid pancreatic lesions. Traditionally, biopsy specimens are processed for cytology, often requiring on-site cytopathology support. This multicenter prospective study evaluated whether directly placing...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer